UA90053U - Method for predicting risk of osteoporosis in patients with systemic lupus erythematosus - Google Patents

Method for predicting risk of osteoporosis in patients with systemic lupus erythematosus

Info

Publication number
UA90053U
UA90053U UAU201314509U UAU201314509U UA90053U UA 90053 U UA90053 U UA 90053U UA U201314509 U UAU201314509 U UA U201314509U UA U201314509 U UAU201314509 U UA U201314509U UA 90053 U UA90053 U UA 90053U
Authority
UA
Ukraine
Prior art keywords
osteoporosis
patients
lupus erythematosus
systemic lupus
predicting risk
Prior art date
Application number
UAU201314509U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Сергій Вікторович Шевчук
Людмила Петрівна Денищич
Original Assignee
Научно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. М.И. Пирогова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. М.И. Пирогова filed Critical Научно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. М.И. Пирогова
Priority to UAU201314509U priority Critical patent/UA90053U/en
Publication of UA90053U publication Critical patent/UA90053U/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A method for predicting the risk of osteoporosis in the patients with systemic lupus erythematosus relates to the rheumatology and comprises the assay for the increased levels of oxyproline, pyridinoline, and homocysteine. The levels of oxyproline >40 µM, pyridinoline > 14 ng/mL, homocysteine >20 µM suggest the risk of osteoporosis.
UAU201314509U 2013-12-11 2013-12-11 Method for predicting risk of osteoporosis in patients with systemic lupus erythematosus UA90053U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201314509U UA90053U (en) 2013-12-11 2013-12-11 Method for predicting risk of osteoporosis in patients with systemic lupus erythematosus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201314509U UA90053U (en) 2013-12-11 2013-12-11 Method for predicting risk of osteoporosis in patients with systemic lupus erythematosus

Publications (1)

Publication Number Publication Date
UA90053U true UA90053U (en) 2014-05-12

Family

ID=52281412

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201314509U UA90053U (en) 2013-12-11 2013-12-11 Method for predicting risk of osteoporosis in patients with systemic lupus erythematosus

Country Status (1)

Country Link
UA (1) UA90053U (en)

Similar Documents

Publication Publication Date Title
EP2966422A4 (en) Method for determining an individual's weight and insole for the implementation thereof
EP2870220A4 (en) Chain drag carbonizer, system and method for the use thereof
BR112015006996A2 (en) method for reducing the amount of sulfur in a composition comprising sulfur, and, composition.
EP3054954A4 (en) Hdac inhibitors, alone or in combination with btk inhibitors, for treating non-hodgkin's lymphoma
HK1218129A1 (en) Method and kit for detecting 1,25-dihydroxyvitamin d and related antibodies 125- d
BR112015023754A2 (en) nanostructured titanium alloy article, and method for fabricating a nanostructured titanium alloy
WO2013184363A3 (en) Location aware reminders
EP3043875A4 (en) Method to determine body's physiological response to physical exercise for assessing readiness and to provide feedback, and system for implementing the method
MX2019010594A (en) Beta-casein a2 and prevention of inflammation of the bowel.
EP3079226A4 (en) Device's state estimation device, device's power consumption estimation device, and program
EP3086790A4 (en) 6-substituted and 7-substituted morphinan analogs and the use thereof
EP2960243A4 (en) Biotin alterant, streptavidin mutant, and uses thereof
EP3003949A4 (en) Method in the installation of an elevator and tool for use in the method
EP3057854A4 (en) Subframe and method for reinforcing the same
GB201303168D0 (en) Immunoassay for detecting kratom, Its constituents and their use
EP3042483A4 (en) Method, apparatus and system for enhancing user's engagement with service
EP3036849A4 (en) Bs and ue, and methods used in the same
UA90053U (en) Method for predicting risk of osteoporosis in patients with systemic lupus erythematosus
GB2513859B (en) Agrochemical composition, method for its preparation and the use thereof
EP3048886A4 (en) 3, 4-bis-benzylsulfonylbutanenitrile and its pharmaceutical use
EP2995923A4 (en) Material-odor-assaying device, assaying retainer used therein, and material-odor-testing method used with said material-odor-assaying device
Batou “The Makhzen Institution in Morocco’s History” by Mohammed Jadour
UA89607U (en) Method for predicting risk of osteoporosis in patients with systemic lupus erythematosus
UA90082U (en) Method for treating osteoporosis in patients with systemic lupus erythematosus
Sheng-Hong The Identification and Education of Civic Morality